Conveners
Technical Session
- Richard Catherall (CERN)
As in the previous years, the target and ion source development group (TISD) has been working to push the limits of beam intensity and purity of available beams, and to develop new beams of elements, which are not yet available at any other ISOL facility. Important progress has been made on the LIEBE project, which exploits the forced circulation of a hot Pb-Bi eutectic melt. Here, the...
The Resonance Ionization Laser Ion Source (RILIS) at ISOLDE is the most frequently used ion source, providing 60% of the ion beams in 2017, and more than 85% in 2016. The ionization mechanism, based on stepwise resonance excitation of an outer electron of the atom, is element selective. For certain elements even isomer-selective ionization can be achieved, enabling the delivery of beams with...
The CERN-MEDICIS laboratory is located in an extension of the CERN-ISOLDE radioactive ion beam facility in Geneva, Switzerland. ISOLDE is able to provide more than 1000 different isotopes by irradiating a thick target with a 1.4 GeV proton beam from the CERN Proton Synchrotron Booster. Since more than 90 % of the proton beam passes through the ISOLDE targets, the MEDICIS targets will be placed...
For many years the RFQcb (Radio-Frequency Quadrupole cooler buncher) has been a vital part of ISOLDE experiments and it has improved the beam optics of the HRS line significantly downstream. However, there is very little time and infrastructure available to test and quantify improvements made to the RFQcb's structure, tuning and bunching methods. The Offline 2 separator was proposed to allow...
